How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

19,011 results for

Pacemaker

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Leadless cardiac pacemaker implantation for bradyarrhythmias

Leadless cardiac pacemaker implantation for bradyarrhythmias L Leadless cardiac pacemak eadless cardiac pacemaker implantation for er implantation for br bradyarrh adyarrhythmias ythmias Interventional procedures guidance Published: 29 August 2018 nice.org.uk/guidance/ipg626 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected (...) , and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Evidence on the safety of leadless cardiac pacemaker implantation for bradyarrhythmias shows

2018 National Institute for Health and Clinical Excellence - Interventional Procedures

2. Pacemaker Essentials: How to Interpret a Pacemaker ECG

Pacemaker Essentials: How to Interpret a Pacemaker ECG Pacemaker Essentials: How to Interpret a Pacemaker ECG - CanadiEM Pacemaker Essentials: How to Interpret a Pacemaker ECG In , by Lorne Costello May 24, 2016 Is that pesky pacemaker still causing you trouble? It means well but sometimes it can rub emergency physicians the wrong way. Let’s shift our focus to the ECG, and hopefully we’ll discover some pearls to help us with these troublesome devices. This is part 2 of a 3 part series. Check (...) out part 1, “ ” if you haven’t already! If you’d like to download a personal version of the above infographic, . The Case It’s Saturday night and you are handed the following ECG. The patient is a 68-year-old male with chest pain. His past medical history is significant for a permanent pacemaker (PPM) that was placed for complete heart block three years ago. His vitals are stable. Does this person actually have a pacemaker? He could. This ECG shows normal sinus rhythm, and this does not rule out

2016 CandiEM

3. Switching Between Transcutaneous Pacemakers: Guidelines

Switching Between Transcutaneous Pacemakers: Guidelines Switching Between Transcutaneous Pacemakers: Guidelines | CADTH.ca Find the information you need Switching Between Transcutaneous Pacemakers: Guidelines Switching Between Transcutaneous Pacemakers: Guidelines Last updated: July 24, 2019 Project Number: RA1055-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What are the evidence-based guidelines regarding care of transcutaneous (...) -paced adult patients who require switching to a different transcutaneous pacemaker? Key Message No relevant evidence-based guidelines were identified regarding care of transcutaneous-paced adult patients who require switching to a different transcutaneous pacemaker. Files Rapid Response Reference List Published : July 24, 2019 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

5. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers

Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers Public Comment: Held April 5 to 26, 2018. Remote Monitoring of Implantable Cardioverter- Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers: Health Quality Ontario Recommendation FINAL RECOMMENDATION • Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommends publicly funding remote monitoring (...) for patients with implantable cardioverter-defibrillators, cardiac resynchronization therapy devices with or without a defibrillator, and permanent pacemakers RATIONALE FOR THE RECOMMENDATION There was consensus among the Ontario Health Technology Advisory Committee members that using remote monitoring improves clinical outcomes without affecting patients’ safety, it is good value for money, and patients report positive experiences with using remote monitoring. 1 Remote Monitoring of Implantable

2018 Health Quality Ontario

6. Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial. (PubMed)

Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial. Permanent artificial pacemaker implantation is a safe and effective treatment for bradycardia and is associated with extended longevity and improved quality of life. However, the most common long-term complication of standard pacemaker therapy is pacemaker-associated heart failure. Pacemaker follow-up is potentially an opportunity to screen for heart (...) failure to assess and optimise patient devices and medical therapy.The study is a multicentre, phase-3 randomised trial. The 1200 participants will be people who have a permanent pacemaker for bradycardia for at least 12 months, randomly assigned to undergo a transthoracic echocardiogram with their pacemaker check, thereby tailoring their management directed by left ventricular function or the pacemaker check alone, continuing with routine follow-up. The primary outcome measure is time to all-cause

2019 BMJ open

7. An enlarging pacemaker pocket: A case report of a plasmablastic lymphoma arising as a primary tumor around a cardiac pacemaker and systematic literature review of various malignancies arising at the pacemaker pocket (PubMed)

An enlarging pacemaker pocket: A case report of a plasmablastic lymphoma arising as a primary tumor around a cardiac pacemaker and systematic literature review of various malignancies arising at the pacemaker pocket To date, there have been limited reports of oncogenesis occurring within pacemaker pockets. We report the case of a 100-year-old male who presented to the emergency department complaining of expansion of his pacemaker pocket over the period of 8 days. Dissection of the pacemaker (...) pocket and pathological analysis of tissue samples revealed plasmablastic lymphoma, a subset of diffuse large B-cell lymphoma, commonly seen in immunocompromised elderly patients. This is the first known reported case of plasmablastic lymphoma occurring within a pacemaker pocket. pacemaker site. A thorough literature review of primary tumors arising around pacemakers is provided

Full Text available with Trip Pro

2017 Journal of cardiology cases

8. Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications

Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Micra (...) transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications. Lansdale: HAYES, Inc. Healthcare Technology Brief Publication. 2017 Authors' conclusions Health Problem: Inadequate slow heart rates (i.e., bradycardia) due to atrioventricular (AV) dysfunction or sinus node dysfunction may result in hemodynamic consequences. A permanent cardiac pacemaker (PM) is the definitive treatment for symptomatic bradycardia that is not caused by underlying disorders or medication. However, overall

2017 Health Technology Assessment (HTA) Database.

9. Leadless pacemakers for right ventricle pacing. Update 2017

Leadless pacemakers for right ventricle pacing. Update 2017 Leadless pacemakers for right ventricle pacing. Update 2017 Leadless pacemakers for right ventricle pacing. Update 2017 Semlitsch T, Posch N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Semlitsch T, Posch N. Leadless pacemakers for right ventricle pacing. Update 2017. Vienna (...) : Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). Decision Support Document. 2017 Authors' objectives This report is the first update of the systematic review on "Leadless pacemakers for right ventricle pacing" prepared in March 2016. Leadless cardiac pacemakers are miniaturised, self-contained intracardiac devices that can be implanted entirely inside the right ventricle of the heart. The expected benefit is the avoidance of complications associated with external pulse generators

2017 Health Technology Assessment (HTA) Database.

10. Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). (PubMed)

Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). 29431664 2018 02 12 1524-4539 137 6 2018 Feb 06 Circulation Circulation Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). 633-635 10.1161/CIRCULATIONAHA.117.030106 Tjong Fleur V Y (...) .). Reddy Vivek Y VY Helmsley Electrophysiology Center, Mount Sinai School of Medicine, New York, NY (V.Y.R.). eng Letter United States Circulation 0147763 0009-7322 arrhythmias, cardiac cardiac pacing, artificial long term adverse effects pacemaker, artificial 2018 2 13 6 0 2018 2 13 6 0 2018 2 13 6 0 ppublish 29431664 CIRCULATIONAHA.117.030106 10.1161/CIRCULATIONAHA.117.030106

Full Text available with Trip Pro

2018 Circulation

11. Living with a pacemaker: patient-reported outcome of a pacemaker system. (PubMed)

Living with a pacemaker: patient-reported outcome of a pacemaker system. The aim of this study was to assess among pacemaker patients their overall satisfaction with the pacemaker system, pain, soreness/discomfort, cosmetic results, restrictions due to impaired movement of the shoulder/arm/chest, related sleep disturbances, and concern about possible device malfunction.The seven-item questionnaire was mailed to patients from a single center who had a pacemaker implant or replacement between (...) associated with reoperation (but not other variables). Overall scores for men and women were 5 vs. 6, respectively, which achieved significance (p = 0.042). Median ratings of pain, soreness/discomfort, cosmetic appearance, range of motion, sleep, and concern about device malfunction were all ≤5. Females reported worse outcomes for all questions, except for cosmetic results and concern about malfunction.The vast majority of patients report excellent overall satisfaction with the pacemaker system

Full Text available with Trip Pro

2018 BMC Cardiovascular Disorders

12. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution? (PubMed)

Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution? Conventional cardiac device infections are increasing in incidence, causing significant morbidity and mortality. Leadless pacemaker (LP) therapy may provide new opportunities for the management of pacemaker (PM) infections as it does not require implantation of transvenous leads and a pectoral pocket.We sought to evaluate the effect of early and late LP implantation in patients (...) diagnosed with device infection.Patients receiving an LP at our center after conventional PM lead extraction due to infection between December 1, 2013 and November 30, 2017 were included.A total of 17 patients (mean age 77.4 ± 7.77 years) underwent LP implantation (ie, 11 with Nanostim leadless cardiac pacemaker [Abbott, Chicago, IL] and 6 with Micra transcatheter pacing system [Medtronic, Minneapolis, MN]) after successful PM system explantation. In 9 PM-dependent patients, a temporary transvenous

2018 Heart Rhythm

13. Leadless Pacemaker Versus Transvenous Single-Chamber Pacemaker Therapy: A Propensity Matched Analysis. (PubMed)

Leadless Pacemaker Versus Transvenous Single-Chamber Pacemaker Therapy: A Propensity Matched Analysis. The recent introduction of leadless pacemakers (PMs) was aimed to eliminate transvenous lead- and pocket-related complications. While the initial results with the leadless PMs seem promising, the nonrandomized nature, limited implant experience of operators, and short follow-up period of these studies preclude a simple comparison to transvenous PMs.The objective of this study was to provide

2018 Heart Rhythm

14. Leadless pacemakers for right ventricle pacing

Leadless pacemakers for right ventricle pacing Leadless pacemakers for right ventricle pacing Leadless pacemakers for right ventricle pacing Kisser A, Emprechtinger R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Kisser A, Emprechtinger R. Leadless pacemakers for right ventricle pacing. Vienna: Ludwig Boltzmann Institut fuer Health (...) Technology Assessment (LBIHTA). Decision Support Document No. 97. 2016 Project page URL Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Cardiac Pacing, Artificial; Heart Ventricles; Humans; Pacemaker, Artificial Language Published English Country of organisation Austria English summary An English language summary is available. Address for correspondence Ludwig Boltzmann Institute fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7 rechte Stiege

2016 Health Technology Assessment (HTA) Database.

15. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE)

Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months.The RM-ALONE is a multicentre

2019 EvidenceUpdates

16. Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluation

Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluation Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluation Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could

2015 NIHR HTA programme

17. Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)

Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail (...) Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government

2017 Clinical Trials

18. Next-generation pacemakers: from small devices to biological pacemakers. (PubMed)

Next-generation pacemakers: from small devices to biological pacemakers. Electrogenesis in the heart begins in the sinoatrial node and proceeds down the conduction system to originate the heartbeat. Conduction system disorders lead to slow heart rates that are insufficient to support the circulation, necessitating implantation of electronic pacemakers. The typical electronic pacemaker consists of a subcutaneous generator and battery module attached to one or more endocardial leads. New leadless (...) pacemakers can be implanted directly into the right ventricular apex, providing single-chamber pacing without a subcutaneous generator. Modern pacemakers are generally reliable, and their programmability provides options for different pacing modes tailored to specific clinical needs. Advances in device technology will probably include alternative energy sources and dual-chamber leadless pacing in the not-too-distant future. Although effective, current electronic devices have limitations related to lead

Full Text available with Trip Pro

2017 Nature reviews. Cardiology

19. Rescue Leadless Pacemaker Implantation in a Pacemaker-Dependent Patient with Congenital Heart Disease and no Alternative Routes for Pacing (PubMed)

Rescue Leadless Pacemaker Implantation in a Pacemaker-Dependent Patient with Congenital Heart Disease and no Alternative Routes for Pacing Congenital heart disease patients are considered a unique group of patients regarding their high risk of conduction abnormalities , whether de novo or surgically induced , and the challenges in both implantation and management of device related complications. We present a case of a pacemaker-dependent patient with congenital heart disease who experienced

Full Text available with Trip Pro

2017 Journal of atrial fibrillation

20. Transvenous dual‐chamber pacemaker after paediatric heart transplantation using left ventricle pacing through the coronary sinus (PubMed)

Transvenous dual‐chamber pacemaker after paediatric heart transplantation using left ventricle pacing through the coronary sinus A 12-year-old child with end-stage heart failure due to restrictive cardiomyopathy was submitted to orthotopic heart transplantation. Primary graft dysfunction required venous arterial extra-corporeal membrane oxygenation. Heart function normalized, but complete atrioventricular block remained after 3 weeks. A dual-chamber pacing with transvenous left ventricle

Full Text available with Trip Pro

2018 ESC heart failure

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>